Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether patient self-report of severe hypoglycemia is associated with increased mortality. RESEARCH DESIGN AND METHODS: Adult patients (N = 1,020) seen in a specialty diabetes clinic between August 2005 and July 2006 were questioned about frequency of hypoglycemia during a preencounter interview; 7 were lost to follow-up and excluded from analysis. Mild hypoglycemia was defined as symptoms managed without assistance, and severe hypoglycemia was defined as symptoms requiring external assistance. Mortality data, demographics, clinical characteristics, and Charlson comorbidity index (CCI) were obtained from the electronic medical record after 5 years. Patients were stratified by self-report of hypoglycemia at baseline, demographics were compared using the two-sample t test, and risk of death was expressed as odds ratio (95% CI). Associations were controlled for age, sex, diabetes type and duration, CCI, HbA1c, and report of severe hypoglycemia. RESULTS: In total, 1,013 patients with type 1 (21.3%) and type 2 (78.7%) diabetes were questioned about hypoglycemia. Among these, 625 (61.7%) reported any hypoglycemia, and 76 (7.5%) reported severe hypoglycemia. After 5 years, patients who reported severe hypoglycemia had 3.4-fold higher mortality (95% CI 1.5–7.4; P = 0.005) compared with those who reported mild/no hypoglycemia. CONCLUSIONS: Self-report of severe hypoglycemia is associated with 3.4-fold increased risk of death. Patient-reported outcomes, including patient-reported hypoglycemia, may therefore augment risk stratification and disease management of patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The primary cause of hypoglycemia is intensification of antihyperglycemic therapy (almost always using SUs [or to a lesser extent glinides] and/or insulin) aimed at achieving lower A1C targets, as demonstrated by intensive therapy trials.1202,1203”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1202]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [195]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An association between selfreported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (91).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587 · cited 1×
“The CCI is an extensively studied and widely used measure that weighs comorbid conditions by the strength of their association with 1-year mortality (17,18); it has been previously validated for use in diabetes (19).”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Cited by
Items 301–400 of 541
Westall, S., Narayanan, R. P., Watmough, S., Irving, G. J., Furlong, N. J., McNulty, S., Bujawansa, S., & Hardy, K. J. (2022) · Clinical Medicine · doi:10.7861/clinmed.2021-0764 · Cited by 13
Giménez, M., Khunti, K., Matsuhisa, M., Chenji, S., Syring, K. E., & Yan, Y. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01466-6 · Cited by 11
Recognizing and minimizing hypoglycemia: The need for individualized care
Lavernia, F., Kushner, P. R., Trence, D., Rice, D., DAILEY, G. E., & Kuritzky, L. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1086628 · Cited by 11
“Hypoglycemia is also reported to lead to increases in hospitalizations and mortality [11,12].”
BackgroundEngineering synthetically modified insulin for glucose-responsive diabetes therapy
Webber, M. J., Anderson, D. G., & Langer, R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1071187 · Cited by 11
“Acute complications, generally occurring from insulin overdose-induced hypoglycemia, can result in coma or death [6], while chronic fluctuations in blood glucose levels increase the long-term risk of developing cardiovascular disease, stroke, non-healing wounds, blindness, cancer and many other co-morbidities [7].”
BackgroundHensel, M., Stuhr, M., Geppert, D., Kersten, J. F., Lorenz, J., & Kerner, T. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.027 · Cited by 10
Thomas, A., Shin, J., Jiang, B., McMahon, C., Kolassa, R., & Vigersky, R. A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817721242 · Cited by 11
“Hypoglycemia of high intensity and low frequency represents clinically “severe” hypoglycemia which is associated with an increased the risk of fatal events.(8) We also investigated which of the hypoglycemic metrics correlates best with the coefficient of variation (CV), a marker of glycemic variability, where CV = 100…”
BackgroundZekarias, K., Kumar, A. F., Moheet, A. A., & Seaquist, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.015 · Cited by 11
SGLT inhibitors for people with type 1 diabetes
Llano, A., McKay, G., & Fisher, M. (2019) · Practical Diabetes · doi:10.1002/pdi.2222 · Cited by 10
Gao, M. H., Giamouridis, D., Lai, N. C., Guo, T., Xia, B., Kim, Y. C., Huu, V. A. N., Skowronska‐Krawczyk, D., Lantier, L., Bhargava, R., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.12.002 · Cited by 11
“For example, only a minority of patients achieve targeted glucose control,(5) and aggressive insulin therapy increases serious hypoglycemic episodes, which shorten life.(6) In addition, the majority of T1D patients develop insulin resistance.”
BackgroundHospital admissions trends for severe hypoglycemia in diabetes patients in Spain, 2005 to 2015
Orozco‐Beltrán, D., Guillen-Mollá, A., Cuenca, A. M. C., Navarro-Pérez, J., Gil-Guillén, V. F., Quesada, J. A., Pomares, F., López‐Pineda, A., & Carratalá‐Munuera, C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108565 · Cited by 10
Gebremichael, G. B., & Mariye, T. (2020) · International Journal of Endocrinology · doi:10.1155/2020/8743531 · Cited by 12
“4 times higher mortality among patients who reported severe hypoglycemia at baseline [4].”
BackgroundAmod, A., Buse, J. B., McGuire, D. K., Pieber, T. R., Pop‐Busui, R., Pratley, R. E., Zinman, B., Hansen, M. B., Jia, T., Mark, T., et al. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120970933 · Cited by 10
Pasciak, W., Berg, D. N., Cherlin, E. J., Fried, T. R., & Lipska, K. J. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02268-w · Cited by 12
A Qualitative Study of Older Adult Perspectives on Continuous Glucose Monitoring for Type 2 Diabetes
Tanenbaum, M. L., Peterson, I., Uratsu, C. S., Chen, M., Gilliam, L. K., Karter, A. J., Gopalan, A., Grant, R. W., & Iturralde, E. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09458-x · Cited by 11
Dalem, J. D. R.-V., Brouwers, M. C. G. J., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., de Vries, F., & Burden, A. M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13168 · Cited by 9
Martín, Zhou, Y., Takagi, T., & Tian, Y. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01410-x · Cited by 11
Zhou, Y., Mai, X., Deng, H., Yang, D., Zheng, M., Huang, B., Xu, L., Weng, J., Xu, W., & Yan, J. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13296 · Cited by 10
Liu, A., Fan, Z., Lu, X., Wu, Y., Zhao, W., Lou, X., Hu, J.-H., & Peng, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.977278 · Cited by 9
“In the diabetic, frequent severe hypoglycemia was associated with increased risks of cardiovascular events (30), brain damage (31), retinopathy (32), and death (33).”
BackgroundAlexiadis, A., Tsanas, A., Shtika, L., Efopoulos, V., Votis, K., Tzovaras, D. K., & Triantafyllidis, A. K. (2024) · IEEE Access · doi:10.1109/access.2024.3350201 · Cited by 12
“Research has shown that people with diabetes with an episode of severe hypoglycaemia during the last 5 years, had a 3.4-fold increased risk of death than those with mild or no hypoglycaemia [8].”
InfluentialKim, M. K., Jung, H. S., Kwak, S. H., Cho, Y. M., Park, K. S., & Kim, S. Y. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.284 · Cited by 10
Fujibayashi, K., Hayashi, M., Yokokawa, H., & Naito, T. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0187-8 · Cited by 9
Holbrook, T., Tang, Y., Das, R., Shankar, R. R., Tunceli, K., Williams, J. W., Radican, L., Holden, S. E., Morgan, C., Piercy, J., et al. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12958 · Cited by 10
Iloh, G. U. P., & Amadi, A. (2018) · Journal of Health Research and Reviews · doi:10.4103/jhrr.jhrr_37_17 · Cited by 14
Can hypoglycemic episodes in type 1 diabetics trigger cardiac arrhythmias?
Lainetti, K. R., Pimenta, J., & Vendramini, M. F. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107878 · Cited by 11
Stefenon, P., da Silveira, A. L. M., Giaretta, L. S., Leitão, C. B., & Bauer, A. C. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-0521-z · Cited by 9
Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998–2018
Jensen, M. H., Hejlesen, O. K., & Vestergaard, P. (2021) · Diabetologia · doi:10.1007/s00125-021-05507-2 · Cited by 10
Lin, N.-P., Zheng, N., Purushottam, L., Zhang, Y. W., & Chou, D. H. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.859133 · Cited by 9
“Chronic hyperglycemia can lead to cardiovascular diseases, nephropathy, non-healing wounds, and other diabetic complications, whereas hypoglycemia can result in acute coma or even death (McCoy et al., 2012; Frier, 2014).”
BackgroundWan, E. Y. F., Yu, E. Y. T., Fung, C. S. C., Chin, W., Fong, D., Chan, A. K. C., & Lam, C. L. K. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.012 · Cited by 11
A Novel Earwax Method to Measure Acute and Chronic Glucose Levels
Herane-Vives, A., Espinoza, S., Sandoval, R., Ortega, L., Alameda, L., Young, A. H., Arnone, D., Hayes, A., & Benöhr, J. (2020) · Diagnostics · doi:10.3390/diagnostics10121069 · Cited by 9
“Whereas some studies have shown reduced HbA1c associated with a larger risk of hypoglycemia [17], others have found an increased risk of hypoglycemia with higher HbA1c [18,19].”
BackgroundMcCoy, R. G., SWARNA, K. S., Neumiller, J. J., Polley, E. C., Deng, Y., Mickelson, M. M., & Herrin, J. S. (2024) · Clinical Diabetes · doi:10.2337/cd24-0007 · Cited by 8
Self-citationGilliam, L. K., Parker, M. M., Chen, M., Karter, A. J., & GRANT, R. W. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.59946 · Cited by 8
Cardioprotective antihyperglycemic drugs ameliorate endoplasmic reticulum stress
Mooradian, A. D., & Haas, M. J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00470.2023 · Cited by 8
Rosenstock, J., BAJAJ, H. S., Lingvay, I., & Heller, S. R. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003930 · Cited by 12
Kohli, M., Pandey, P., Jakhmola, V., Saha, S., Chaudhary, M., Ansori, A. N. M., & Negi, A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01648-y · Cited by 10
Muller, N., Lehmann, T. N., Gerste, B., Adler, J., Kloos, C., Hartmann, M., Kramer, G., Kuniß, N., & Müller, U. (2017) · Diabetic Medicine · doi:10.1111/dme.13397 · Cited by 8
Argente, M., Martínez-Millana, A., Espí-Reig, J., Maupoey, J., Moya‐Herraiz, Á., Castelló, I. B., López‐Andújar, R., & Merino-Torres, J. F. (2021) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2021.10.001 · Cited by 8
Xin, X., Chen, J., Chen, L., Wang, J., Liu, X., & Chen, F. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134929 · Cited by 8
Iwahori, T., Snoek, F. J., Nagai, Y., Spaepen, E., Mitchell, B. D., & Peyrot, M. F. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01211-5 · Cited by 9
Nimri, R., Murray, N., Ochs, A., Pinsker, J. E., & Dassau, E. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.2504 · Cited by 8
Body Mass Index–Mortality Relationship in Severe Hypoglycemic Patients With Type 2 Diabetes
Tsai, T.-C., Lee, C., Cheng, B., Kung, C., Chen, F.-C., Shen, F., Lee, C.-J., & Chen, Y.-C. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000382 · Cited by 9
“4-fold higher risk of death after 5 years compared with those who reported mild or no hypoglycemic symptoms.(14) Therefore, patients with diabetes who developed severe hypoglycemia had inferior outcomes and higher mortality rates than patients with diabetes.”
BackgroundMeulstee, M., Whittemore, R., & Watts, S. A. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715606805 · Cited by 9
“The 2 VHA experts and 3 experts outside this system differed in opinion on including the subcategory of “veterans with T2DM.””
BackgroundInfluentialWong, C. K. H., Tong, T., Cheng, G. H. L., Tang, E. H. M., Thokala, P., Tse, E. T. Y., & Lam, C. L. K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13657 · Cited by 7
Hung, W.-T., Chen, Y.-J., Cheng, C.-Y., Ovbiagele, B. I., Lee, M., & Hsu, C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109937 · Cited by 9
Leung, S. S., Lenchik, N. I., Mathews, C. E., Pugliese, A., McCarthy, D. A., Bagge, S. L., Ewing, A. D., Harris, M. A., Radford, K. J., Borg, D. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39243-x · Cited by 7
“Here, we observed the following in donor pancreata from those with type 1 diabetes; (1) islet GCG expression is associated with increases in AGER and changes in AGER correlated genes, (2) genes correlated with AGER in GCG hi donor islets are enriched for biological pathways relating to glucagon secretion, (3) islet AG…”
BackgroundMinamoto-Higashioka, M., Kawamura, R., Umakoshi, H., Yokomoto‐Umakoshi, M., Utsunomiya, D., Osawa, H., & Kondo, S. (2019) · Internal Medicine · doi:10.2169/internalmedicine.1360-18 · Cited by 8
“Results from several studies suggest that hypoglycemia increases the risk of acute cardiovascular events (4), falls (5) and fall-related fractures (6), the progression of dementia (7, 8), and all-cause mortality (8-12).”
BackgroundAhammed, A., Pathan, F., Afsana, F., Ahammed, I., Mir, A. S., & Yusuf, A. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_338_17 · Cited by 7
“Indian Journal of Endocrinology and Metabolism ¦ Volume 22 ¦ Issue 4 ¦ July-August 2018500 study done by McCoy et al.[5] found that self-report of severe hypoglycemia is associated with 3.4-fold increased risk of death.”
BackgroundInfluentialA Wearable, Low-cost Hand Tremor Sensor for Detecting Hypoglycemic Events in Diabetic Patients
Abbas, H. T., Zahed, K., Alić, L., Zhu, Y., Sasangohar, F., Mehta, R. K., Lawley, M., Abbasi, Q. H., & Qaraqe, K. A. (2018) · IEEE International RF and Microwave Conference · doi:10.1109/rfm.2018.8846546 · Cited by 8
“In addition to health-related quality-of-life issues (sleep, driving, employment), the short-term complications include neurocognitive dysfunction, temporal loss of vision, and may result in eventual loss of life [3].”
BackgroundMcCoy, R. G., Lipska, K. J., Houten, H. K. V., & Shah, N. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001878 · Cited by 7
Self-citationHayes, K. N., Berry, S. D., Munshi, M. N., & Zullo, A. R. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18360 · Cited by 7
A review of hypoglycaemia in a South African family practice setting
Pillay, D. K., Ross, A. J., & Campbell, L. (2016) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v8i1.1095 · Cited by 8
Hypoglycaemia manifestations and recurrent events: L essons from the SAVOR‐TIMI 53 outcome study
Cahn, A., Mosenzon, O., Bhatt, D. L., Leibowitz, G., Yanuv, I., Rozenberg, A., Iqbal, N., Hirshberg, B., Stahre, C., Im, K., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12903 · Cited by 7
Quirós, C., Viñals, C., Giménez, M., Roca, D., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.03.009 · Cited by 7
Visser, M. M., Muylder, A. V., Charleer, S., Isitt, J. J., Roze, S., Block, C. E. M. D., Maes, T., Vanhaverbeke, G., Nobels, F. R. E., Keymeulen, B., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06084-2 · Cited by 6
“Self-reported severe hypoglycaemia is associated with a 3.4-fold increased risk of death [37], with FoH being one of the main barriers to achieving good glycaemic control in type 1 diabetes [38], as people with FoH intentionally maintain higher glucose levels, leading to higher HbA 1c [39].”
InfluentialKarter, A. J., Parker, M. M., Huang, E. S., Seligman, H. K., Moffet, H. H., Ralston, J. D., Liu, J. Y., Gilliam, L. K., Laiteerapong, N., Grant, R. W., et al. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08801-y · Cited by 6
“Among patients with diabetes, severe hypoglycemia has been associated with a tripling of the risk of mortality, 20–23 as well as substantial increases in cognitive decline, 24–28 stroke, 29 falls, 30,31 fall-related fractures, 32 motor vehicle accidents, 33 and cardiovascular events; 34–36 as well…”
Long-term outcomes and challenges of islet transplantation in type 1 diabetes
Chetboun, M., & Pattou, F. N. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00003-8 · Cited by 6
Sorkin, D. H., Billimek, J., August, K. J., Ngo‐Metzger, Q., Kaplan, S. H., Reikes, A., & Greenfield, S. (2015) · Family Practice · doi:10.1093/fampra/cmv014 · Cited by 6
Bishop, E., Allington, D., Ringrose, T., Martin, C. E., Aldea, A., Maira, G., Vargas, F. M. L., Leal, Y., Henao, D. C., & Gómez, A. M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221136141 · Cited by 7
Eisenson, D. L., Hisadome, Y., Santillan, M. R., & Yamada, K. (2022) · Frontiers in Transplantation · doi:10.3389/frtra.2022.989811 · Cited by 6
“Diabetes is a leading cause of both cardiovascular disease and end stage renal disease (ESRD) (3, 4), and carries particularly high short-termmortality in patients with hypoglycemic unawareness (5).”
BackgroundIwasaki, S., Kozawa, J., Kimura, T., Fukui, K., Iwahashi, H., Imagawa, A., & Shimomura, I. (2017) · Diabetology International · doi:10.1007/s13340-017-0303-5 · Cited by 6
Zahed, K., Sasangohar, F., Mehta, R. K., Erraguntla, M., Lawley, M., & Qaraqe, K. A. (2018) · Proceedings of the Human Factors and Ergonomics Society Annual Meeting · doi:10.1177/1541931218621278 · Cited by 5
“Given that recurrent hypoglycemic episodes increase the risk of death by at least 3 folds (McCoy et al., 2012), it is vital that patients with diabetes properly recognize its early onset and act accordingly.”
BackgroundGlucose-sensitive materials for delivery of antidiabetic drugs
Saeed, M., & ElShaer, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102548-2.00009-3 · Cited by 5
Stantonyonge, N., Martínez‐Horta, S., Sampedro, F., Sánchez‐Saudinós, M. B., & Chico, A. I. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108898 · Cited by 5
Galdo, J. A., Thurston, M. M., & Bourg, C. A. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.2.66 · Cited by 5
The Traditions and Risks of Fasting for Lipid Profiles in Patients with Diabetes
Aldasouqi, S. A., & Grunberger, G. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.11.2837 · Cited by 5
Cooper, M. N., de Bock, M. I., Carter, K. W., de Klerk, N. H., Jones, T. W., & Davis, E. A. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.11.022 · Cited by 5
Sulfonylureas and meglitinides: insights into physiology and translational clinical utility
Lebovitz, H. E., & Melander, A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch42 · Cited by 6
Dang, N.-A. T., Vu, P. T., Gammeltoft, T. M., Bygbjerg, I. C., Meyrowitsch, D. W., & Søndergaard, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290355 · Cited by 4
Jaya, M. K. A., Rahmawati, F., Yasin, N. M., & Ikawati, Z. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998375680250509052027 · Cited by 5
Keinosuke, I., Fujita, H., Kimura, N., Nagase, H., Wakasa, Y., Tsuruta, S., Muroya, T., & Hakamada, K. (2025) · Pancreas · doi:10.1097/mpa.0000000000002508 · Cited by 4
“29,31 32 – 34 Type 3c-DM is also associated with microvascular and macrovascular complications, similar to T1DM and T2DM.”
Ensuring Patient Safety During the Transition to ESRD
Wagner, L.-A., & Fink, J. C. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.12.009 · Cited by 4
Hajime, M., Okada, Y., Mori, H., Uemura, F., Sonoda, S., Tanaka, K., Kurozumi, A., Narisawa, M., Torimoto, K., & Tanaka, Y. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0412-3 · Cited by 5
Glucose monitoring in diabetes: from clinical studies to real‐world practice
Sagar, R. C., Abbas, A., & Ajjan, R. (2019) · Practical Diabetes · doi:10.1002/pdi.2215 · Cited by 5
Neue Therapieoptionen mit kontinuierlich gemessenen Glukosedaten – Empfehlungen für die Praxis
Seufert, J., Deiss, D., Gölz, S., Haak, T., Klausmann, G., Kroeger, J., Lobmann, R., Pfeiffer, A. F. H., Schnell, O., Seibold, A., et al. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0978-4537 · Cited by 4
“[45] McCoy RG, Van Houten HK, Ziegenfuss JY et al.”
BackgroundSulfonylurea derivatives and risk of hypoglycaemia in type 2 diabetic patients
Svěcený, J., Jirušková, J., Hrach, K., Radovnická, L., & Laštůvka, J. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.114 · Cited by 6
Rodríguez‐Gutiérrez, R., Salcido‐Montenegro, A., González‐González, J. G., & McCoy, R. G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001906 · Cited by 5
“30 31 Data from glucometers and continuous glucose monitors (CGMs), while valuable, is also not commonly available in the EHR, whether due to patients not using these devices (particularly in developing countries) or the inability of many practices, particularly in primary care, to consistently…”
Self-citationBlissett, D. B., Attvall, S., & Hellmund, R. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01099-7 · Cited by 4
“In addition to costs avoided, reducing the risk of severe hypoglycaemic events has additional health benefits not captured in the model; these include avoiding detriments to patient’s quality of life associated with severe hypoglycaemic events [33] and reducing risk of further complications or death [34].”
BackgroundTremamunno, S., Tartaglione, L., Telesca, A., Rizzi, A., Felici, T., Mazzotta, F. A., Vita, A. D., Rizzo, E., Cambise, N., Belmusto, A., et al. (2024) · Endocrine · doi:10.1007/s12020-023-03651-w · Cited by 5
Kintzoglanakis, K., Pavlou-Skantzis, L., Themeli, T., Kyprianou, M., & Paschou, S. Α. (2024) · HORMONES · doi:10.1007/s42000-024-00545-y · Cited by 5
“These benefits could apply provided that inappropriate intensification of therapy in older multimorbid PwD [18] and hypoglycemia [14, 18, 19] can be avoided.”
Omar, M. A. K., Kok, A., Khutsoane, D., Joshi, S., Ramaboea, M., Mashitisho, M. L. I., Chetty, V., Koopman, L. J., Johnson, L., & on behalf of the IO HAT investigator group (2017) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2017.1385966 · Cited by 4
Zaccardi, F., Husemoen, L. L. N., Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., & Khunti, K. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.01.006 · Cited by 4
“In large cohorts severe hypoglycaemia has been linked to all-cause and cause-specific mortality [7, 25-27]: it remains”
BackgroundBala, C. G., Rusu, A., Moise, M., & Román, G. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0020 · Cited by 4
“Intensification of diabetes management to achieve optimal diabetes control is frequently associated with hypoglycemic episodes [26,27] and severe hypoglycemia has been associated with cognitive impairment [28], increased risk of dementia [29], and increased mortality [30,31].”
BackgroundUnnikrishnan, A., Saboo, B., Joshi, S., Kesavadev, J., Makkar, B. M., Agarwal, S., Aravind, S. R., Seshadri, K., Chawla, M. S., Deshpande, N., et al. (2019) · PubMed · Cited by 7
Argente, M., Martínez-Millana, A., Espí-Reig, J., Maupoey, J., Moya‐Herraiz, Á., Castelló, I. B., López‐Andújar, R., & Merino-Torres, J. F. (2020) · Cirugía Española · doi:10.1016/j.ciresp.2020.09.012 · Cited by 4
Biomarkers associated with severe hypoglycaemia and death in ACCORD
Chow, L. S., CHEN, H.-Y. P., Miller, M. E., Marcovina, S. M., & Seaquist, E. R. (2015) · Diabetic Medicine · doi:10.1111/dme.12883 · Cited by 4
Tanaka, N., & Hiura, Y. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0610 · Cited by 4
Mazzi, S., Ravasio, R., Forlani, G., Veronese, G., Fabbri, A., & Marchesini, G. (2017) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s148368 · Cited by 6
“Hypoglycemia (especially when severe) systematically increases the risk of death.(5,6) In any case, it produces a significant reduction in patients’ quality of life, with effects on cognitive, behavioural, and emotional status.”
Quirós, C., Viñals, C., Giménez, M., Roca, D., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.03.013 · Cited by 7
McGown, P. J., Papanikolaou, N., El-Taraboulsi, J., Britton, C., Iqtidar, J., Chaudhry, K., Ng, S., Jethwa, K., Patel, J., Reed, J., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70174 · Cited by 3
“11 Hypoglycaemia is a cause of significant morbidity and mortality in diabetes, 12 and it is also acknowledged that fear of hypoglycaemia is a barrier to optimal glycaemic control.”
Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges
Bhagi, M., Kaur, J., Dhar, A., & Bhat, A. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010287216240324050651 · Cited by 4
IN CONTROL of type 1 diabetes, despite hypoglycaemia unawareness
Youssef, J. E. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30261-3 · Cited by 3
Patient Possession of Excess Medication Supply in the VA: A Retrospective Database Study
Linsky, A. M., Stolzmann, K. L., Simon, S. R., Cabral, H., & Rosen, A. K. (2019) · Medical Care · doi:10.1097/mlr.0000000000001211 · Cited by 3
“1–3 2,881,675 (61) 0 686,393 (15) Medication level Medications with a copay All 1,005,537 (21) Some 426,814 (9)”
Is hypoglycemia expensive in China?
Lan, K., Wang, J., Nicholas, S., Tang, Q., Chang, A., & Xu, J. (2021) · Medicine · doi:10.1097/md.0000000000024067 · Cited by 3
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
Harris, S. B., Parente, E. B., & Karalliedde, J. J. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01247-7 · Cited by 3
Horii, T., Otsuka, M., & Yasu, T. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003177 · Cited by 3
Prevalence of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus in Osun State, Nigeria
Airaodion, A. I., Ijioma, C. E., Ejikem, P. I., Abali, I. O., Aminu-Ayinde, O. E., Ogwu, C. I., Kalesanwo, E. A., Amuta, A. C., Areh, J. E., Odarah, J. E., et al. (2023) · Direct Research Journal of Health and Pharmacology · doi:10.26765/drjhp20198426375 · Cited by 6
Charitou, M. M., & Al-Bahadili, H. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_15 · Cited by 3
Bhagra, S., Ducharme‐Smith, A., Juntunen, M. B., Liedl, C. P., Golembiewski, E. H., Sundt, W. J. S., Krpata, T. S., Lampman, M. A., Espinoza, A. L., & McCoy, R. R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322177 · Cited by 5
Self-citationTang, Y., Liu, J., Hannachi, H., Engel, S. S., Ganz, M. L., & Rajpathak, S. N. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0512-3 · Cited by 4
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_22 · Cited by 3
Heitkemper, E., Wilcox, G. B., Zuniga, J. A., Kim, M. T., & Cuevas, H. E. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231158828 · Cited by 4
Metadata
- Authors
- McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A.
- Affiliations
- Mayo Clinic (US)
- Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
- Corresponding author
- Smith, Steven A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1897-1901
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425008
- OpenAlex
- W2153957843
- Semantic Scholar
- 28fffca9598fb24277bf9ea60849e4ad6060f499
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 34 · 2023: 37 · 2022: 46 · 2021: 35 · 2020: 46 · 2019: 59 · 2018: 36 · 2017: 43 · 2016: 50 · 2015: 49 · 2014: 39 · 2013: 24 · 2012: 3
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, diabetes mortality, patient self-report, patient-reported outcomes, type 1 diabetes, type 2 diabetes, risk stratification, Charlson Comorbidity Index, HbA1c, diabetes complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Retrospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.